Coronado Biosciences, Inc. (CNDO)

[JT460]

8-K (Dec 13, 2013) Study investigator Eric Hollander, M.D., reports potential benefits of TSO immunotherapy in first 5 patients

“On December 12, 2013, Coronado Biosciences, Inc. issued a press release announcing that Dr. Eric Hollander, Clinical Professor of Psychiatry and Behavioral Sciences at Albert Einstein College of Medicine of Yeshiva University and Director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore Medical Center and Einstein, presented interim data from his pilot study of oral TSO (Trichuris suis ova or CNDO-201) to treat autism at the American College of Neuropsychopharmacology Annual Meeting in Hollywood, Florida. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference”

http://www.sec.gov/Archives/edgar/data/1429260/000119312513472496/d643608d8k.htm

Exhibit 99.1

http://www.sec.gov/Archives/edgar/data/1429260/000119312513472496/d643608dex991.htm